Systemic and vascular markers of inflammation in relation to metabolic syndrome and insulin resistance in adults with elevated atherosclerosis risk
Authors:
- Gaby KresselGKGaby Kressel
- Birgit TrunzBTBirgit Trunz
- Achim BubABAchim Bub
- Olaf HülsmannOHOlaf Hülsmann
- Maike WoltersMWMaike Wolters
- Ralf LichtinghagenRLRalf Lichtinghagen
- Dirk O. StichtenothDSDirk O. Stichtenoth
- Andreas HahnAndreas Hahn
- 1 January 2009
- journal article
- Published by Elsevier in Atherosclerosis
- Vol. 202 (1) , 263-271
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- The Metabolic Syndrome: Inflammation, Diabetes Mellitus, and Cardiovascular DiseaseThe American Journal of Cardiology, 2006
- Diagnosis and Management of the Metabolic SyndromeCirculation, 2005
- C-reactive protein is not only an inflammatory marker but also a direct cause of cardiovascular diseasesMedical Hypotheses, 2004
- Biological determinants of serum ICAM-1, E-selectin, P-selectin and L-selectin levels in healthy subjects: the Stanislas studyAtherosclerosis, 2004
- Relationship of Metabolic Syndrome and Fibrinolytic Dysfunction to Cardiovascular DiseaseCirculation, 2003
- Inflammation in atherosclerosisNature, 2002
- Soluble adhesion molecules and prediction of coronary heart disease: a prospective study and meta-analysisThe Lancet, 2001
- Plasminogen-Activator Inhibitor Type 1 and Coronary Artery DiseaseNew England Journal of Medicine, 2000
- Impact of Adipose Tissue on Plasma Plasminogen Activator Inhibitor-1 in Dieting Obese WomenArteriosclerosis, Thrombosis, and Vascular Biology, 1999
- Circulating adhesion molecules in diseaseImmunology Today, 1993